Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

May 2003

Volume 993 NEUROPROTECTIVE AGENTS: Sixth International Conference

Pages ix–ix, 1–393

  1. Article: Frontmatter

    1. Top of page
    2. Article: Frontmatter
    3. Article: Session I: Clinical Trials and Beyond
    4. Article: Session II: Clinical Application of Neuroprotective Approaches
    5. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    6. Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    7. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    8. Article: Session IV: Models of Neurotoxicity and Neuroprotection
    9. Article: Session V: Modulators of Neurotoxicity and Neuroprotection
    10. Article: Session VI: Mechanisms of Neuroprotection
    11. Article: Session VII: Oxidative Stress, Mitochondria, and Approaches to Neuroprotection
    12. Article: Session VIII: Genomic Approaches to Understanding Neurotoxicity and Neuroprotection
    1. Preface (page ix)

      William Slikker Jr., Russell J. Andrews and Bruce Trembly

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07505.x

  2. Article: Session I: Clinical Trials and Beyond

    1. Top of page
    2. Article: Frontmatter
    3. Article: Session I: Clinical Trials and Beyond
    4. Article: Session II: Clinical Application of Neuroprotective Approaches
    5. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    6. Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    7. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    8. Article: Session IV: Models of Neurotoxicity and Neuroprotection
    9. Article: Session V: Modulators of Neurotoxicity and Neuroprotection
    10. Article: Session VI: Mechanisms of Neuroprotection
    11. Article: Session VII: Oxidative Stress, Mitochondria, and Approaches to Neuroprotection
    12. Article: Session VIII: Genomic Approaches to Understanding Neurotoxicity and Neuroprotection
    1. Evaluation of Topiramate Neuroprotective Effect in Severe TBI Using Microdialysis (pages 25–34)

      OSCAR L. ALVES, AIDEN J. DOYLE, TOBIAS CLAUSEN, CHARLOTTE GILMAN and ROSS BULLOCK

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07508.x

    2. Melatonin Ameliorates Neurologic Damage and Neurophysiologic Deficits in Experimental Models of Stroke (pages 35–47)

      RUSSEL J. REITER, ROSA M. SAINZ, SILVIA LOPEZ-BURILLO, JUAN C. MAYO, LUCIEN C. MANCHESTER and DUN XIAN TAN

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07509.x

  3. Article: Session II: Clinical Application of Neuroprotective Approaches

    1. Top of page
    2. Article: Frontmatter
    3. Article: Session I: Clinical Trials and Beyond
    4. Article: Session II: Clinical Application of Neuroprotective Approaches
    5. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    6. Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    7. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    8. Article: Session IV: Models of Neurotoxicity and Neuroprotection
    9. Article: Session V: Modulators of Neurotoxicity and Neuroprotection
    10. Article: Session VI: Mechanisms of Neuroprotection
    11. Article: Session VII: Oxidative Stress, Mitochondria, and Approaches to Neuroprotection
    12. Article: Session VIII: Genomic Approaches to Understanding Neurotoxicity and Neuroprotection
    1. Gene Therapy and Hypothermia for Stroke Treatment (pages 54–68)

      MIDORI A. YENARI, HENG ZHAO, RONA G. GIFFARD, RAYMOND A. SOBEL, ROBERT M. SAPOLSKY and GARY K. STEINBERG

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07511.x

    2. EEG Deficits in Chronic Marijuana Abusers during Monitored Abstinence : Preliminary Findings (pages 75–78)

      RONALD I. HERNING, WARREN BETTER, KIMBERLY TATE and JEAN L. CADET

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07513.x

  4. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection

    1. Top of page
    2. Article: Frontmatter
    3. Article: Session I: Clinical Trials and Beyond
    4. Article: Session II: Clinical Application of Neuroprotective Approaches
    5. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    6. Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    7. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    8. Article: Session IV: Models of Neurotoxicity and Neuroprotection
    9. Article: Session V: Modulators of Neurotoxicity and Neuroprotection
    10. Article: Session VI: Mechanisms of Neuroprotection
    11. Article: Session VII: Oxidative Stress, Mitochondria, and Approaches to Neuroprotection
    12. Article: Session VIII: Genomic Approaches to Understanding Neurotoxicity and Neuroprotection
    1. The Molecular Effects of Alcohol : Clues to the Enigmatic Action of Alcohol (pages 82–94)

      MEENA KUMARI, ANTJE ANJI, HENRI WOODS JR. and MAHARAJ K. TICKU

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07515.x

    2. Effect of Ethanol on Lipid-Mediated Transfection of Primary Cortical Neurons (pages 95–102)

      ANTJE ANJI, KAMRAN A. SHAIK and MEENA KUMARI

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07516.x

  5. Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection

    1. Top of page
    2. Article: Frontmatter
    3. Article: Session I: Clinical Trials and Beyond
    4. Article: Session II: Clinical Application of Neuroprotective Approaches
    5. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    6. Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    7. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    8. Article: Session IV: Models of Neurotoxicity and Neuroprotection
    9. Article: Session V: Modulators of Neurotoxicity and Neuroprotection
    10. Article: Session VI: Mechanisms of Neuroprotection
    11. Article: Session VII: Oxidative Stress, Mitochondria, and Approaches to Neuroprotection
    12. Article: Session VIII: Genomic Approaches to Understanding Neurotoxicity and Neuroprotection
    1. Antiepileptic Drugs and Apoptosis in the Developing Brain (pages 103–114)

      PETRA BITTIGAU, MARCO SIFRINGER and CHRYSANTHY IKONOMIDOU

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07517.x

  6. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection

    1. Top of page
    2. Article: Frontmatter
    3. Article: Session I: Clinical Trials and Beyond
    4. Article: Session II: Clinical Application of Neuroprotective Approaches
    5. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    6. Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    7. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    8. Article: Session IV: Models of Neurotoxicity and Neuroprotection
    9. Article: Session V: Modulators of Neurotoxicity and Neuroprotection
    10. Article: Session VI: Mechanisms of Neuroprotection
    11. Article: Session VII: Oxidative Stress, Mitochondria, and Approaches to Neuroprotection
    12. Article: Session VIII: Genomic Approaches to Understanding Neurotoxicity and Neuroprotection
    1. Neurotoxicity of Nitrous Oxide and Ketamine Is More Severe in Aged than in Young Rat Brain (page 115)

      J. K. BEALS, L. B. CARTER and V. JEVTOVIC-TODOROVIC

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07518.x

    2. Chronic Exposure to NMDA Receptor and Sodium Channel Blockers during Development in Monkeys and Rats : Long-Term Effects on Cognitive Function (pages 116–122)

      MERLE G. PAULE, C. MATTHEW FOGLE, RICHARD R. ALLEN, EDWIN C. PEARSON, TIMOTHY G. HAMMOND and E. JON POPKE

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07519.x

  7. Article: Session IV: Models of Neurotoxicity and Neuroprotection

    1. Top of page
    2. Article: Frontmatter
    3. Article: Session I: Clinical Trials and Beyond
    4. Article: Session II: Clinical Application of Neuroprotective Approaches
    5. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    6. Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    7. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    8. Article: Session IV: Models of Neurotoxicity and Neuroprotection
    9. Article: Session V: Modulators of Neurotoxicity and Neuroprotection
    10. Article: Session VI: Mechanisms of Neuroprotection
    11. Article: Session VII: Oxidative Stress, Mitochondria, and Approaches to Neuroprotection
    12. Article: Session VIII: Genomic Approaches to Understanding Neurotoxicity and Neuroprotection
    1. Estrogen as a Neuroprotective Agent in the Treatment of Spinal Cord Injury (pages 125–133)

      ERIC ANTHONY SRIBNICK, JAMES MICHAEL WINGRAVE, DEBORAH DENISE MATZELLE, SWAPAN KUMAR RAY and NAREN LAL BANIK

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07521.x

    2. N-Methyl-d-aspartate and TrkB Receptor Activation in Cerebellar Granule Cells : An In Vitro Model of Preconditioning to Stimulate Intrinsic Survival Pathways in Neurons (pages 134–145)

      XUEYING JIANG, DAMING ZHU, PETER OKAGAKI, ROBERT LIPSKY, XUAN WU, KRISHNA BANAUDHA, KAREN MEAROW, KENNETH I. STRAUSS and ANN M. MARINI

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07522.x

    3. Neuroprotection or Neurotoxicity : Impact of Discontinuous Dose-Response Curves on Risk Assessment (page 158)

      WILLIAM SLIKKER JR., HELEN DUHART, DAVID GAYLOR and SYED IMAM

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07524.x

  8. Article: Session V: Modulators of Neurotoxicity and Neuroprotection

    1. Top of page
    2. Article: Frontmatter
    3. Article: Session I: Clinical Trials and Beyond
    4. Article: Session II: Clinical Application of Neuroprotective Approaches
    5. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    6. Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    7. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    8. Article: Session IV: Models of Neurotoxicity and Neuroprotection
    9. Article: Session V: Modulators of Neurotoxicity and Neuroprotection
    10. Article: Session VI: Mechanisms of Neuroprotection
    11. Article: Session VII: Oxidative Stress, Mitochondria, and Approaches to Neuroprotection
    12. Article: Session VIII: Genomic Approaches to Understanding Neurotoxicity and Neuroprotection
    1. Mating Attenuates Aging-Associated Increase of Lipid Peroxidation Activity in C57BL/6J Mice (pages 161–167)

      GREGORY F. OXENKRUG and PURA J. REQUINTINA

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07526.x

    2. Hypoxic Preconditioning Prevents Cortical Infarction by Transient Focal Ischemia-Reperfusion (pages 168–178)

      ANYA M.Y. LIN, SHIANG-WEN DUNG, CHAU-FONG CHEN, WEN-HAN CHEN and LOW-TONE HO

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07527.x

    3. Environmental Conditions Unexpectedly Affect the Long-Term Extent of Cell Death Following an Hypoxic Episode (pages 179–194)

      ROBERT L. ISAACSON, JEANNE M. FAHEY and FADWA AL MUGHAIRBI

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07528.x

  9. Article: Session VI: Mechanisms of Neuroprotection

    1. Top of page
    2. Article: Frontmatter
    3. Article: Session I: Clinical Trials and Beyond
    4. Article: Session II: Clinical Application of Neuroprotective Approaches
    5. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    6. Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    7. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    8. Article: Session IV: Models of Neurotoxicity and Neuroprotection
    9. Article: Session V: Modulators of Neurotoxicity and Neuroprotection
    10. Article: Session VI: Mechanisms of Neuroprotection
    11. Article: Session VII: Oxidative Stress, Mitochondria, and Approaches to Neuroprotection
    12. Article: Session VIII: Genomic Approaches to Understanding Neurotoxicity and Neuroprotection
    1. Possible Mechanism for the Neuroprotective Effects of l-Carnitine on Methamphetamine-Evoked Neurotoxicity (pages 197–207)

      ASHRAF VIRMANI, FRANCO GAETANI, SYED IMAM, ZBIGNIEW BINIENDA and SYED ALI

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07530.x

    2. Prostaglandins of J Series Control Heme Oxygenase Expression : Potential Significance in Modulating Neuroinflammation (pages 208–216)

      HEAN ZHUANG, YUN-SOOK KIM, KHODADAD NAMIRANIAN and SYLVAIN DORÉ

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07531.x

    3. Multiple Sclerosis and Glutamate (pages 229–275)

      ANTHONY J. GROOM, TERENCE SMITH and LECHOSLAW TURSKI

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07533.x

    4. Potential Mechanism by Which Resveratrol, a Red Wine Constituent, Protects Neurons (pages 276–286)

      HEAN ZHUANG, YUN-SOOK KIM, RAYMOND C. KOEHLER and SYLVAIN DORÉ

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07534.x

  10. Article: Session VII: Oxidative Stress, Mitochondria, and Approaches to Neuroprotection

    1. Top of page
    2. Article: Frontmatter
    3. Article: Session I: Clinical Trials and Beyond
    4. Article: Session II: Clinical Application of Neuroprotective Approaches
    5. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    6. Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    7. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    8. Article: Session IV: Models of Neurotoxicity and Neuroprotection
    9. Article: Session V: Modulators of Neurotoxicity and Neuroprotection
    10. Article: Session VI: Mechanisms of Neuroprotection
    11. Article: Session VII: Oxidative Stress, Mitochondria, and Approaches to Neuroprotection
    12. Article: Session VIII: Genomic Approaches to Understanding Neurotoxicity and Neuroprotection
    1. The Acute Effects of Acrylamide on Astrocyte Functions (pages 296–304)

      MICHAEL ASCHNER, CHENG-CHEN CAO, QI WU and MARVIN A. FRIEDMAN

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07537.x

    2. 3-Nitropropionic Acid Inhibition of Succinate Dehydrogenase (Complex II) Activity in Cultured Chinese Hamster Ovary Cells : Antagonism by l-Carnitine (pages 305–312)

      ANDREW C. SCALLET, RANEY L. HALEY, DORI M. SCALLET, HELEN M. DUHART and ZBIGNIEW K. BINIENDA

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07538.x

    3. Systemic Vitamin D3 Attenuated Oxidative Injuries in the Locus Coeruleus of Rat Brain (pages 313–324)

      KUEN-BOR CHEN, ANYA MAAN-YUH LIN and TSAI-HSIEN CHIU

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07539.x

    4. Mitochondria as a Target for Neurotoxins and Neuroprotective Agents (pages 334–344)

      SERGEY O. BACHURIN, ELENA P. SHEVTSOVA, ELENA G. KIREEVA, GREGORY F. OXENKRUG and SERGEY O. SABLIN

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07541.x

  11. Article: Session VIII: Genomic Approaches to Understanding Neurotoxicity and Neuroprotection

    1. Top of page
    2. Article: Frontmatter
    3. Article: Session I: Clinical Trials and Beyond
    4. Article: Session II: Clinical Application of Neuroprotective Approaches
    5. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    6. Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    7. Article: Session III: NMDA Receptors as Mediators of Neurotoxicity/Protection
    8. Article: Session IV: Models of Neurotoxicity and Neuroprotection
    9. Article: Session V: Modulators of Neurotoxicity and Neuroprotection
    10. Article: Session VI: Mechanisms of Neuroprotection
    11. Article: Session VII: Oxidative Stress, Mitochondria, and Approaches to Neuroprotection
    12. Article: Session VIII: Genomic Approaches to Understanding Neurotoxicity and Neuroprotection
    1. The Role of Caspase III Inhibition in Methamphetamine-Induced Alterations in p53 and bcl-2 Expression : Correlation with Dopaminergic Neurotoxicity (page 350)

      SYED Z. IMAM, MICHELLE OETINGER, JOHN T. SKINNER, W. SLIKKER JR. and SYED F. ALI

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07543.x

    2. Cocaine Induces a Dose-Dependent Alteration in the Expression of Immediate Early Genes c-fos and SP-1 and in Nuclear Factor NF-κβ in PC12 Cells (page 362)

      SYED Z. IMAM, HELEN M. DUHART, JOHN T. SKINNER and SYED F. ALI

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07545.x

    3. Amyloid Processing and Signal Transduction Properties of Antiparkinson-Antialzheimer Neuroprotective Drugs Rasagiline and TV3326 (pages 378–386)

      MOUSSA B.H. YOUDIM, TAMAR AMIT, ORIT BAR-AM, MARTA WEINSTOCK and MERAV YOGEV-FALACH

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1749-6632.2003.tb07548.x

SEARCH

SEARCH BY CITATION